Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic

Affiliations

¹ From the Department of Neuroinflammation (W.B., O.C.), Queen Square MS Centre, UCL Queen Square Institute of Neurology, London, United Kingdom; Department of Neurology (D.B.), Oregon Health & Science University, Portland, OR; Menzies Health Institute Queensland (S.B.), Griffith University, Gold Coast Campus, Queensland, Australia; Department of Neurology (J.K.), Amsterdam University Medical Center, Amsterdam, the Netherlands; and University College London Hospitals NIHR Biomedical Research Centre (O.C.), London, United Kingdom. w.brownlee@ucl.ac.uk.
² From the Department of Neuroinflammation (W.B., O.C.), Queen Square MS Centre, UCL Queen Square Institute of Neurology, London, United Kingdom; Department of Neurology (D.B.), Oregon Health & Science University, Portland, OR; Menzies Health Institute Queensland (S.B.), Griffith University, Gold Coast Campus, Queensland, Australia; Department of Neurology (J.K.), Amsterdam University Medical Center, Amsterdam, the Netherlands; and University College London Hospitals NIHR Biomedical Research Centre (O.C.), London, United Kingdom.

Wallace Brownlee et al. Neurology. 2020.

. 2020 Jun 2;94(22):949-952.

doi: 10.1212/WNL.0000000000009507. Epub 2020 Apr 2.

¹ From the Department of Neuroinflammation (W.B., O.C.), Queen Square MS Centre, UCL Queen Square Institute of Neurology, London, United Kingdom; Department of Neurology (D.B.), Oregon Health & Science University, Portland, OR; Menzies Health Institute Queensland (S.B.), Griffith University, Gold Coast Campus, Queensland, Australia; Department of Neurology (J.K.), Amsterdam University Medical Center, Amsterdam, the Netherlands; and University College London Hospitals NIHR Biomedical Research Centre (O.C.), London, United Kingdom. w.brownlee@ucl.ac.uk.
² From the Department of Neuroinflammation (W.B., O.C.), Queen Square MS Centre, UCL Queen Square Institute of Neurology, London, United Kingdom; Department of Neurology (D.B.), Oregon Health & Science University, Portland, OR; Menzies Health Institute Queensland (S.B.), Griffith University, Gold Coast Campus, Queensland, Australia; Department of Neurology (J.K.), Amsterdam University Medical Center, Amsterdam, the Netherlands; and University College London Hospitals NIHR Biomedical Research Centre (O.C.), London, United Kingdom.

No abstract available

Comment in

Response to letter 'Lymphocyte counts and the risk of COVID-19 in people with MS'.
Loonstra FC, van Kempen ZL, Strijbis EM, Killestein J, Hoitsma E, Mostert JP. Loonstra FC, et al. Mult Scler. 2021 Sep;27(10):1626-1627. doi: 10.1177/1352458520965468. Epub 2020 Oct 16. Mult Scler. 2021. PMID: 33064043 No abstract available.